Auxly Cannabis Group Stock Net Asset
| XLY Stock | CAD 0.09 0.01 6.25% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Auxly Cannabis' long-term financial health and intrinsic value.
Auxly |
Auxly Cannabis Group Company Net Asset Analysis
Auxly Cannabis' Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Auxly Cannabis Net Asset | 261.53 M |
Most of Auxly Cannabis' fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Auxly Cannabis Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, Auxly Cannabis Group has a Net Asset of 261.53 M. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The net asset for all Canada stocks is notably lower than that of the firm.
Auxly Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Auxly Cannabis' direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Auxly Cannabis could also be used in its relative valuation, which is a method of valuing Auxly Cannabis by comparing valuation metrics of similar companies.Auxly Cannabis is currently under evaluation in net asset category among its peers.
Auxly Fundamentals
| Return On Equity | -0.2 | |||
| Return On Asset | 0.0351 | |||
| Profit Margin | (0.13) % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 161.75 M | |||
| Shares Outstanding | 1.28 B | |||
| Shares Owned By Insiders | 21.25 % | |||
| Shares Owned By Institutions | 0.16 % | |||
| Number Of Shares Shorted | 9.67 M | |||
| Price To Book | 0.94 X | |||
| Price To Sales | 0.89 X | |||
| Revenue | 122.33 M | |||
| Gross Profit | 59.93 M | |||
| EBITDA | 23.58 M | |||
| Net Income | (16.35 M) | |||
| Cash And Equivalents | 14.64 M | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 51.6 M | |||
| Debt To Equity | 1.20 % | |||
| Current Ratio | 2.58 X | |||
| Book Value Per Share | 0.09 X | |||
| Cash Flow From Operations | 16.78 M | |||
| Short Ratio | 12.72 X | |||
| Earnings Per Share | (0.01) X | |||
| Target Price | 0.02 | |||
| Number Of Employees | 388 | |||
| Beta | 0.98 | |||
| Market Capitalization | 109.13 M | |||
| Total Asset | 261.53 M | |||
| Retained Earnings | (499.62 M) | |||
| Working Capital | (46.69 M) | |||
| Annual Yield | 46.20 % | |||
| Net Asset | 261.53 M |
About Auxly Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Auxly Cannabis Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Auxly Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Auxly Cannabis Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in Auxly Stock
Auxly Cannabis financial ratios help investors to determine whether Auxly Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Auxly with respect to the benefits of owning Auxly Cannabis security.